Submit Deal

MYRIAD GENETICS

Summary

Myriad Genetics is a provider of genetic testing and precision medicine.

Deals Overview

Total Deals4

Valued Deals2

Total Value£ 94 M

Avg. Deal Size£ 47 M

Market Context

Senior Management

Paul J. Diaz
President and CEO
Matt Scalo
Senior Vice President, Investor Relations
Megan Manzari
Senior PR Manager

Sort

31 May 2016|Germany|Health Care Services

Target: SIVIDON DIAGNOSTICS

Bidder: MYRIAD GENETICS

2 Service Providers

1 Target | 1 Bidder

10 Dealmakers

5 Target | 5 Bidder

£ 38 M

Value

03 Aug 2016|United States|Medical Services

Target: ASSUREX HEALTH INC

Bidder: MYRIAD GENETICS

1 Service Providers

1 Target

1 Dealmakers

1 Target

n/a

Value

03 May 2021|United States|Test Inspection and Certification (TIC)

Target: MYRIAD GENETICS (VECTRA TESTING BUSINESS)

Bidder: LABCORP

3 Service Providers

2 Bidder | 1 Vendor

5 Dealmakers

3 Bidder | 2 Vendor

n/a

Value

01 Nov 2022|United States|Biotechnology

Target: GATEWAY GENOMICS

Bidder: MYRIAD GENETICS

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 55 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy